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ABSTRACT
Nitric oxide (NO), a member of the reactive nitrogen species 
family, plays a role in several physiologic processes, including 
vasculogenesis and angiogenesis, growth and puberty, and 
senescence and apoptosis. NO plays an important role in the 
production of ovarian steroids, ovulation, and follicular apoptosis. 
In other words, increased activity of nitric oxide synthase (NOS) 
leads to an increased amount of NO, which triggers production 
of prostaglandins and inflammatory cascades which facilitate 
follicular rupture and atresia. NO concentration elevation inhibits 
steroid synthesis in luteal and granulosa cells. Since NO is a 
major paracrine mediator of various biological processes, as 
well as a key factor in both the reproductive cycle and embryo 
implantation, oversynthesis of NO in the uterus results in toxicity 
and inflammation in epithelial cells and immunorejection of 
implantation. In the male physiological system, NO synthesized by 
NOS plays a major role in erectile function and androgen secretion, 
as well as semen parameters, and oocyte junction to the sperm. 
Furthermore, this supposedly simple molecule is involved in a 
number of other functions, such as germ cell evolution, connections 
between sertoli cells and germ cells in the blood-testis barrier, 
homodynamic contraction, and germ cell apoptosis. Moreover, NO 
is considered a key factor in male fertility due to its widespread 
distribution in both normal and diseased testis tissue. The difference 
of expression level of NOS in normal and pathological states is a 
probable cause of fertility destructive processes.
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1. Introduction 
  Nitric oxide (NO) is a short half-time gas (about a few seconds) 
which has diverse biochemical and physiological potentials. This 
molecule was initially discovered in 1978 and nominated as the 
molecule of the year in the 1992[1,2]. This molecule is an inner cell 
and intra-cell messenger which plays a key role in the maintenance 
of body hemostasis[2]. NO usually accomplishes its purpose through 
synthesizing cyclic guanosine monophosphate. In the production 
of NO from the L-arginine, its synthesis is mediated by nitric oxide 
synthase (NOS). This enzyme exists in three isoforms: nervous, 
endothelial, and induction[1]. NO cascade activates different 
pathways in the various tissues, e.g., they emerge as a vasodilator 
factor and a known endothelium-derived relaxing factor in the 
cardiovascular system[2]. However, in the nervous system, NO is 
considered as a neurotransmitter. Also, in some cases, it is involved 
in neutrophil-induced cell toxicity, platelet aggregation, blood flow, 
synaptic transmission, and long-term memory loss[3,4]. In addition to 
aforementioned functions, NO involves in ovulation, menstruation, 
and sperm capacity and motility[5,6]. NO is an important paracrine 
messenger, which participates in several physiological and 
pathophysiological events in the elementary and endocrine organs[7]. 
Furthermore, NO has some roles in immune system, such as 
antiviral and antimicrobial effects, excitation and suppression of the 
immune system, and cytoprotection[8].
2. NO sources in the body
2.1. NO sources
  In mammals, NO can be generated by three isoforms of NO 
synthase including nervous NOS (nNOS), endothelial NOS 
(eNOS), and inducible NOS (iNOS). Mitochondrial NOS has been 
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discovered recently, which is specifically found in mitochondrion[9]. 
Furthermore, iNOS and eNOS are localized in different reproductive 
tissues such as granulosa, theca cells and cytoplasm of oocytes. Most 
apoptotic cascades result in producing reactive nitrogen species and 
reactive oxygen species[9]. 
2.2. Mechanisms of nitric oxide synthesis
  All isoforms of NOS utilize L-arginine as the substrate, 
and molecular oxygen and reduced nicotinamide-adenine-
dinucleotide phosphate (NADPH) as co-substrates. A functional 
NOS transfers electrons from NADPH to the haem in the amino-
terminal oxygenase domain[4,10]. At the haem site, the electrons are 
used to reduce and activate oxygen (O2) and to oxidize L-arginine to 
L-citrulline and NO[11]. To synthesize nitric oxide, the NOS enzyme 
must pass two key steps, including hydroxylating L-arginine to 
Nv-hydroxy-L-arginine and also oxidizing Nv-hydroxy-L-arginine 
to L-citrulline and NO[12-14]. Binding to calcium via calmodulin 
in nNOS and eNOS is done by using an increase in intracellular 
calcium ion (Ca2+). When calmodulin affinity to NOS increases, it 
triggers the transport of electrons from NADPH in the reductase 
domain to the haem in the oxygenase domain. Due to the presence 
of different amino acids in the iNOS structure, calmodulin is 
able to bind at extremely low intracellular Ca2+ concentrations 
approximately 40 nM[15,16]. 
  The ovary is an organ that undergoes major structural and functional 
changes during the reproductive cycle[17]. Luteolysis is the structural 
and functional degradation of the corpus luteum which occurs at 
this cycle and indicates a decrease in cellular function. Analysis 
of corpus luteum in healthy ovaries is accompanied by increased 
production of reactive oxygen species such as O2 and H2O2. One of 
the results of the free radical production in ovarian tissue has been 
the lipid peroxidation in the plasma membrane of the corpus luteum, 
which may lead to loss of gonadotropin receptors, reduce adenylyl 
cyclase–cyclic AMP cyclic adenosine monophosphate (cAMP) 
formation, and finally reduce steroidization of the corpus luteum 
following its destruction[18].  
  Previous studies have shown that NO plays an important role 
in maintaining the physiological balance of organs including the 
ovary[19]. Motta et al[20] reported a direct link between a destruction 
of the corpus luteum and an increase in ovarian prostaglandin F2. 
They stated that corpus luteum depletion was directly related to 
decreased ovarian glutathione production. Also, their study showed 
that increased NO through the mechanism of ovarian glutathione 
depletion could increase the oxidizing effect of oxidase substances 
and lead to destruction of the corpus luteum[21]. Another study from 
the same group showed the effect of NO on the ovary and stated that 
corpus luteum depletion may increase as a result of increased lipid 
oxidation by using L-NG-nitro-arginine methyl ester hydrochloride 
(L-NAME) to prevent the production of intracellular NO in the 
ovary[21,22].
3. NO in the female genital system 
3.1. Oocyte 
  Full comprehension of the meiosis cell division program has not 
yet been accomplished. However, more evidence indicates NO 
involvement in meiosis administration. NO possesses an essential 
physiologic role in oocyte maturation and fertilization, embryo 
development, and fetal implantation[23-25]. eNOS and iNOS are 
reported to be synthesized in the mammalian oocyte, and their 
presence has been confirmed during follicular maturity. NO 
synthesis inhibition in the in vivo maturation of oocytes causes a 
reduction in the number of blastocysts and increases apoptosis in the 
fetus. Alternatively, high levels of NO cause disruption in meiosis 
development and fetus development in the cow, along with a delay 
in the restart (or resumption) of meiosis[25]. Goud et al demonstrated 
NO is a crucial factor in the maintenance of oocyte quality[26]. An 
investigation of earlier literature reveals the binary role of NO in 
oocyte maturity. Moreover, Bu et al described how the concentration 
dependence of NO has effects on oocyte maturity in the rat. For 
instance, NO produced from eNOS activity triggers oocyte maturity 
in the cumulus cells. Nevertheless, a higher concentration of NO 
causes meiosis arrest of oocyte. Before ovulation, NO reduction 
following the sudden increase in luteinizing hormone production 
(luteinizing hormone surge) can be act as a key agent in the restart 
(or resumption) of meiosis[27]. Recent evidence has validated 
that oocytes are able to block meiosis in the diplotene phase by 
expressing iNOS, which produces a sufficient amount of NO[28]. 
Abbasi et al reported that a cAMP cascade is the inducer platform of 
NO which starts meiosis in the rat oocyte, though cyclic guanosine 
monophosphate cascades support the inhibitory effort of NO[29] 
(Figure 1).
3.2. Follicular growth and maturation 
  Pituitary gonadotropin is a key regulator of the final steps of 
follicular evolution, and current data emphasize the balance between 
autocrine and/or paracrine factors in normal follicular growth. NO 
presence in the follicular liquid has been proven in several animal 
species. NOS expression in the follicles exhibits an inner ovarian 
scheme to synthesize NO and to manage follicular growth. NO 
is synthesized by several ovarian cell types, as well as ovarian 
arteries. The ovarian macrophages remove apoptotic cells during 
specific phases of tissue remodeling, as opposed to the removal 
of foreign debris macrophages, which is another source of NO in 
ovarian tissue[6]. These macrophage‐rich regions of the ovary, such 
as the theca layer, corpus luteum, and atretic follicles, are involved 
in the phagocytosis of atretic granulosa cells and apoptotic luteal 
cells[30,31].
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3.3. Ovary
  The iNOS and eNOS have several roles in the ovulation process[6]. 
NO synthesis increases with follicle growth, and this NO increase 
is related to increased estrogen. There are similar changes in 
the amount of NO in circulation with the growth of follicles in 
women undergoing in vitro fertilization. NO is continuously treated 
with the gonadotropin releasing hormone and human chorionic 
gonadotropic hormone, and other hormones, such as luteinizing 
hormone, follicle stimulating hormone, and progesterone have been 
observed[5]. The use of NOS inhibitors intraperitoneally inhibits 
ovulation in rats, which is evidence of the role of NO in ovulation 
processes[30]. These findings suggest that NO is involved in the 
regulation of ovarian functions[31]. Stimulation of the ovary with 
gonadotropins increases the expression of both iNOS and eNOS 
genes and this suggests that both NO isoforms play a role in the 
ovulation process. Inhibition of iNOS by using specific inhibitors 
of NG-Methyl-L-arginine and aminoguanidine inhibitors leads to 
dose-dependent inhibition of ovulation in rats, which indicates the 
role of iNOS in the ovulation process[30]. During follicular growth, 
eNOS is expressed in theca cells and in the granulosa cells of the 
follicle wall, and after ovulation, eNOS is expressed in the yellow 
body. In the immature ovary and during follicular development, 
iNOS expression occurs in the theca cells and stroma cells, and 
after ovulation, iNOS is expressed in the outer layers of the yellow 
body. Estimating the quantity of iNOS suggests that unlike eNOS, 
iNOS concentration does not change during follicular growth[6]. 
Since theca cells, luteal granulosic cells, and yellow body cells are 
involved in steroidogenesis, it can be concluded that NO also plays 
a role in regulating steroid synthesis. In most organs of the body, 
iNOS is expressed only in response to an immune stimulation, such 
as infection or trauma, and the physiological association of iNOS 
expression in the natural ovaries at all stages is still uncertain. It 
is possible that the reduction of expression or non-expression is 
mainly due to the presence of macrophages and interleukin-1毬 in 
the ovary, and it is also possible that NO derived from iNOS acts as 
a monitoring/growth support molecule. Interleukin-1毬 is a stimulant 
for NO synthesis in humans and cows’ fallopian tubes[6]. On the 
other hand, glucose increases in the middle of the menstrual cycle, 
and glucose stimulates NO synthesis. Therefore, it is possible that 
NO and glucose can interact as follicles or inducers and facilitate 
follicular growth pathways[6]. Sugino et al reported a relationship 
between the concentration of NO in follicular fluid and apoptosis, 
where small follicles show more apoptosis, in contrast to large and 
moderate-sized follicles. However, the concentration of NO (nitrite/
nitrate), arginine, and citrulline is not different in these follicles[32]. 
Furthermore, the concentration of NO is increased in human 
follicular fluid, and this increase is directly related to follicle volume 
and estradiol concentration. Taken together, these observations 
suggest that the local production of NO causes follicular growth and 
inhibits apoptosis[33].
Figure 1. Role of nitric oxide (NO) in different parts of male (left side) and female (right side) genital system.  
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3.4. Oviduct (fallopian tube)
  In the uterine tube, increased contraction due to endothelin in 
the presence of L-NAME, an NO synthesis inhibitor, was the first 
evidence of the role of NO in the regulation of the functions of 
the uterine tube[5]. NO regulates contractile activity in the human 
fallopian tube by using prostaglandins, prostacyclin and cAMP, so 
it even prevents tubal ectopic pregnancy[34]. Various studies confirm 
the presence of calcium-dependent, as well as NOS-dependent, 
calcium-shaped forms in the rat, cow, and human fallopian tube, 
and immunohistochemical studies confirm the presence of eNOS in 
the epithelial cells of the uterine tube[35,36]. Although the activity of 
NOS in the uterus during the proestrus phase is relatively less than 
in the other stages of the estrous cycle, the distribution of calcium-
dependent NOS in the isthmus, fimbriae, and ampulla of uterine 
tube is the same[36]. It appears that the release of NO could stimulate 
sperm motility and protect the egg and sperm from damage caused 
by free oxygen radicals[6]. Also, NO may affect the movements of the 
epidermal cells of the uterine tube. NO has been shown to regulate 
some growth factor receptors, such as the epidermal growth factor, 
binding proteins and integrin[37]. In contrast to the physiological 
state, NO synthesis in the uterine tube can be increased under certain 
pathological conditions, such as infection or endometriosis that leads 
to reduced fertility through a destructive or toxic effect on sperm 
cells as well as oocytes. In addition, the increased production of NO 
may affect the movements of cilia and thus embryo transfer, and the 
final result can be miscarriage[6].
3.5. Uterus
  NO regulates the contraction of smooth muscle cells and uterus 
dilation during pregnancy; therefore, the role of NO in the regulation 
of pathophysiology and uterine biology has been considered to be 
significant[38]. The presence of NOS in the glandular epithelium, 
endometrial stromal cells, smooth muscle cells, and mast cells 
indicates the role of NO in the control of the functions of the uterus. 
In addition, local NO synthesis in the uterus may be important for 
regulating myometrial activity, such as contraction and relaxation 
of the uterus[39]. Although smooth muscle cells express eNOS[40], 
the myometrium is one of the rare parts of uterine tissue which 
iNOS expresses in non-provocative implications[41], including 1) 
facilitating the uterine traction for removal of the remaining placenta 
of the uterus after parturition with nitroglycerin, 2) preventing 
preterm delivery and prolonging pregnancy with nitroglycerin, and 
3) reducing the power of uterine contractions induced by oxytocin 
with amyl nitrate that this issue indicates the role of NO in regulating 
and controlling uterine contractions during pregnancy[6]. A study 
conducted by Bansal et al showed that the expression of iNOS rather 
than eNOS and nNOS in humans in preterm labor was the highest. 
It is possible that the increase in NOS activity during pregnancy due 
to positive regulation of cytokines and reduction afterwards during 
childbirth is highly related to inhibitory cytokines[42]. Interaction 
between cyclooxygenase, NO, and cytokine has been proven in the 
uterus of the mouse, and these factors may regulate the function of 
the uterus during pregnancy[43]. Ovarian hormones also induce iNOS 
expression in the uterus and may regulate the function of the uterus. 
However, the role of eNOS in epithelial cells and endometrial stroma 
is still unclear. But, it is possible that continuous production of NO 
through the synthesis of prostaglandin and through binding proteins 
facilitates processes such as menstruation and implantation. A NO 
derivative of eNOS which is the result of activating the production of 
guaniline cyclase solution or the decomposition of cyclooxygenase 
functions as an inhibitor of endometrial platelet aggregation[6]. 
Buhimschi et al showed that the cervix expresses all three NOS 
isoforms. In addition, the expression of iNOS increases during 
normal and preterm labor in the cervix and decreases in the uterus, 
and nNOS, which is not expressed in the uterus during pregnancy, 
increases during childbirth in the cervix[41]. During childbirth, 
regardless of the presence of iNOS and nNOS, there is no significant 
change in the expression of the eNOS gene. These findings 
indicate that NOS activity in the uterus and cervix has a different 
function and concentration during childbirth and may play a role in 
reconstructing the connective tissue during cavity preparation. The 
physiological and biological relevance of NO during pregnancy and 
childbirth shows that the NO synthesis inhibitor (meaning L-NAME) 
prolongs the delivery time and also reduces the opening of external 
orifice of the uterus (external os) and vagina[41,44].
3.6. Placenta and preeclampsia
  Both eNOS and iNOS genes are expressed in the placenta, and eNOS 
expression in the fetal and placental vessels occurs in patients whose 
preeclampsia increases[45]. Placental vessels are more important 
in the pathophysiology of preeclampsia, and it seems eNOS is 
important in conditions such as preeclampsia. NO biosynthesis 
increases with advancing gestation during normal pregnancy 
and decreases in preeclampsia, and eNOS is expressed in human 
placental syncytiotrophoblasts and extravillous trophoblasts[43,45]. In 
fact, it may increase eNOS gene expression in the fetal and placental 
vessels in patients with preeclampsia who have an adaptive response 
to low perfusion and hypoxia. The study conducted by Buhimschi et 
al indicated that administration of L-NAME to pregnant mice leads 
to a condition similar to preeclampsia[41]. 
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4. NO in the male reproductive system
4.1. Testis
  NO has also been identified in the testicular vasculature 
endothelium, and its mechanism of action has been partially 
specified. Accordingly, it is seen that NO can be effective in 
testicular perfusion, activation of gonadotropins and its migratory 
pathway to the Leydig cells of the testes, and affect androgen 
displacement[39]. NO in the testes is involved in regulating blood 
flow, cell permeability, and contractile function of myofibroblasts, 
as well as in regulating steroid synthesis. Also, NO regulates sperm 
motility, as in a low NO concentration increases sperm motility 
and a medium (or high) concentration reduces sperm motility. In 
human semen (seminal fluid), a positive correlation between the 
concentration of NO and the percentage of sperm without mobility 
was observed[46]. Under physiological conditions, NO is produced 
in a small amount, and it causes the free radicals to scavenge, 
which is one of the main causes of decreasing sperm motility. In 
contrast, excessive NO production under pathological conditions, 
such as infection, varicocele, or diabetes mellitus, can cause sperm 
toxicity and also reduce sperm motility through the formation of 
peroxynitrite. It is likely that the sperm ejaculated into the female 
reproductive tract can lead to an immune response, which induces 
iNOS activity and produces a large amount of NO, which can cause 
the non-maturation and capacity of sperm[46]. Hence, the presence of 
endogenous NO inhibitor in seminal plasma can play a physiological 
role in inhibiting NOS activity and maintaining NO in low 
concentrations to prevent toxic injuries to sperm and Leydig cells or 
to suppress hypermotility of the sperm associated with the capacity-
building process[47] (Figure 1).
4.2. Erection
  In humans, NOS activity in the pelvic mesh, cavernous sinus nerves 
in penile tissue, dorsal branches of the penis, and deep arteries of the 
sinus cavernous is observed[6]. NOS activity in the rat penile neurons 
(which autonomically innervated corpus cavernosum and entered the 
glans cavernous tissue) and in the neural network in the adventitia 
layer of the penile vessels, shows that NO is a physiological 
mediator of erectile function. Apart from expression in the nerves, 
eNOS is abundantly expressed in the penile endothelium and the 
corpus cavernosum of the endothelium sinusoidum[40]. Different 
findings indicate that all three iNOS, nNOS, and eNOS genes are 
expressed in smooth muscle cells of the cavernous sinus of the 
penis. Administration of anti-androgenic drug to healthy rats reduces 
the expression of nNOS and eNOS genes and reduces erection[48]. 
Ignarro et al also showed that the electrical stimulation of the 
isolated cell line from the Corpus cavernosum of the rabbit secretes 
NO into the intestine. Based on these findings, they suggested that 
erection is caused by NO and occurs in response to a nonadrenergic-
noncholinergic neurotransmitter. In addition, direct injection of 
L-NAME into periventricular nucleuses leads to inhibition of 
apomorphine and oxytocin (as an erection inducer)[6].
5. Conclusion and future perspectives
  NO is a lipophilic molecule with a short half-life and is synthesized 
by many organs in the body. It is also introduced as an intra-cell 
messenger directing many physiologic cascades. Among other 
things, NO associates with cell growth, apoptosis, and reproduction 
signal transduction, as well as regulation of blood flow in sexual 
organs, regulation of vascular tonicity, genital tracts formation, 
and defense mechanisms. NO reacts with oxygen-active species, 
thiol groups, and proteins. Considering its concentration and site of 
action, it is able to protect or poison cells. NO is a nitrogen-active 
species which plays a role in most physiologic processes, such as 
vasculogenesis and angiogenesis, growth and puberty, senescence 
and apoptosis. In the male physiologic system, NO, which is 
synthesized by NOS, plays a significant role in physiological 
cascades, such as erectile function and androgen secretion, as well as 
sperm motility, maturity, quality, and capacity, and oocyte binding to 
the sperm. Furthermore, this supposedly simple molecule is involved 
in other functions, such as germ cell evolution, connections between 
Sertoli cells and germ cells in the blood-testis barrier, homodynamic 
contraction, and germ cell apoptosis. Moreover, NO is considered 
as a key factor in male fertility due to its widespread distribution 
in both normal and diseased testis tissue. The expression levels of 
eNOS and iNOS are different in the normal or pathological state, and 
overexpression of these two isoforms is a probable cause of fertility 
destructive processes, including low sperm motility and viability, 
disruption of testis tissue, induction of apoptosis in the germ cells, 
and, literally, perturbation of spermatogenesis. NO is an important 
factor in fabricating ovarian steroids, ovulation, and follicular 
apoptosis. iNOS is the major isoform in the ovulation process. 
In other words, increased activity of iNOS leads to an increased 
amount of NO, which triggers production of prostaglandins and 
runs inflammatory cascades which can cause follicular rupture and 
atresia. NO concentration elevation avoids steroid synthesis in the 
luteal and granulosa cells. Since NO is a major paracrine mediator 
of various biological processes and plays a key role in both the 
reproductive cycle and embryo implantation, oversynthesis of NO in 
the uterus results in toxicity and inflammation in epithelial cells and 
immunorejection of implantation.
  Currently, the number of infertile couples has increased 
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dramatically as different forms include decreased fertilization rates, 
increased levels of abortion and high level of morbidity. Increased 
NO level is one of the main chemical and physiopathological factors 
in this regard.
  Due to different roles of NO and a variety of functions in the 
molecular signaling of male and female reproductive system, 
scientific community needs new technology and synthetic materials 
to detect, recognize, and control its level. Paradoxical role of NO 
in both pathologic and physiologic processes depends on general 
state of body and oxidant-antioxidant balance system, thus using the 
antioxidants acts to improve levels of NO.
Conflict of interest statement
   There is no conflict of interest to declare.
Acknowledgments
  The authors would like to express their gratitude to the School 
of Medicine, Sabzevar University of Medical Sciences, Sabzevar, 
Iran for their support. Also, The authors appreciate  of the Research 
Council of Shahrekord University of Medical Sciences.
Authors’ contributions
  Ayoob Rostamzadeh designed this study and Amir Raoofi drafted 
the manuscript. Reza Ahmadi and Mahdi Heydari helped to draft 
the manuscript. All authors read and approved the final manuscript.
References
[1]  Tuteja N, Chandra M, Tuteja R, Misra MK. Nitric oxide as a unique 
bioactive signaling messenger in physiology and pathophysiology. Biomed 
Res Int 2004; 2004(4): 227-237.
[2]  Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. 
J Pharmacol Sci 2015; 129(2): 83-94.
[3]  Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase 
in chronic inflammation and cancer. Cancer Res 2007; 67(4): 1407-1410.
[4]  Forstermann U, Sessa WC. Nitric oxide synthases: Regulation and 
function. Eur Heart J 2012; 33(7): 829-837.
[5]  Wang J, He Q, Yan X, Cai Y, Chen J. Effect of exogenous nitric oxide on 
sperm motility in vitro. Biol Res 2014; 47(1): 44.
[6]  Li J, Zhang W, Zhu S, Shi F. Nitric oxide synthase is involved in follicular 
development via the PI3K/AKT/FoxO3a pathway in neonatal and 
immature rats. Animals 2020; 10(2): 248.
[7]  Lanas A. Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther 
2008; 10(Suppl 2): S4.
[8]  Cuzzocrea S, Mazzon E, Calabro G, Dugo L, De Sarro A, Van De Loo 
FA, et al. Inducible nitric oxide synthase — knockout mice exhibit 
resistance to pleurisy and lung injury caused by carrageenan. Am J Respir 
Crit Care Med 2000; 162(5): 1859-1866.
[9]  Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and 
reactive oxygen species and their regulation. Physiol Rev 2019; 99(1): 
311-379.
[10] Stuehr DJ. Enzymes of the L-arginine to nitric oxide pathway. J Nutrit 
2004; 134(10): 2748S-2751S.
[11] Feng MS, Guo P, Jiang LX, Shi JB, Yao QZ. Synthesis of novel 
methotrexate derivatives with inhibition activity of nitric oxide synthase. 
Chin Chem Lett 2009; 20(2): 178-180. 
[12] Mukherjee P, Cinelli MA, Kang S, Silverman RB. Development of nitric 
oxide synthase inhibitors for neurodegeneration and neuropathic pain. 
Chem Soc Rev 2014; 43(19): 6814-6838.
[13] Jansen Labby K, Li H, Roman LJ, Martásek P, Poulos TL, Silverman 
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